| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |